This general session focuses on the issue of diabetes management in the gerontological patient population. A review of the progression of diabetes over time, issues of pharmacotherapy in the elderly, and current pharmaceutical options for treatment is explored. The importance of dosing adjustments as necessary for
the elderly population and the role of insulin in treating diabetes is also shared.
Contact hours available until 9/21/2015.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure:
Catherine Miller discloses that she is a consultant/member of the speakers’ bureau for Eli Lilly & Company and Amylin Pharmaceuticals.
Planning Committee members have no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.
Objectives:
- Review the progression of diabetes.
- Discuss pharmacotherapy in the elderly.
- Review current pharmacotherapeutic agents for the treatment of diabetes.